TP53 and neoplasm: The tumor mitotic index and p53 immunoreactivity is also often evaluated alongside Ki67 staining as a measure of pituitary NET proliferation, but Ki67 staining has recently been reported to be the more prognostically accurate method, with better inter-rater reliability35.